LEAC-102 for Advanced Colorectal Cancer

ABSTRACT: A Phase I/IIa Dose-Escalation Study Evaluating the Safety, Tolerability and Efficacy of LEAC-102 in Combination with FOLFOX + Bevacizumab/Cetuximab in Subjects with Advanced Colorectal Cancer

DISEASE(S): Colorectal Neoplasms,Advanced Colorectal Cancer

PROVIDER: 2219329 | ecrin-mdr-crc |

REPOSITORIES: ECRIN MDR